RPM adoption surges, but faces future roadblocks: We unpack recent trends on remote patient monitoring usage among doctors and factors preventing further growth.

Reimbursement barriers impede remote patient monitoring growth: Health systems must prove their remote monitoring programs are effective—especially if they want state Medicaid programs to provide coverage.

Healthcare predictions we got right for 2022: As we expected, the lines between healthcare and retail blurred, and consumers cozied up with connected health devices. We detail other predictions we got right for the year.

Nvidia’s new edge AI computing platform highlights the need to protect surgical robots and medical devices from hacking.

We unpack the AMA’s digital health report findings and explore how efficiency is driving RPM adoption.

Health systems address RPM, wearable challenges: We explore new toolkits for scaling RPM adoption, and discuss how healthcare organizations can solve the challenges in adopting the devices.

We detail why their remote monitoring tool is scaling at a time when hospital-at-home momentum is only going to pick up.

The remote patient monitoring market is surging, with the number of US users doubling between 2020 and 2025. Consumers, healthcare providers, payers, and pharma companies are all investing in the technology and programs to improve care and lower cost.

Are virtual clinical trials just as good as in-person? HumanFirst and Duke’s Clinical Research Institute are studying how clinical trials can best use remote monitoring tech—which starts to answer the big question of whether digital health tracking data is reliable enough to inform big healthcare decisions.